103573-92-8 Usage
General Description
[4-(1H-imidazol-1-ylmethyl)phenyl]methanol is a chemical compound with the molecular formula C14H14N2O. It is a white to off-white crystalline powder and is commonly used in pharmaceutical research and development. The compound is known for its potential to act as a ligand for specific receptors in the human body, particularly those involved in the central nervous system. It has been studied for its potential as a treatment for various neurological disorders and has also been investigated for its potential as a building block in the synthesis of other pharmaceutical compounds. Additionally, [4-(1H-imidazol-1-ylmethyl)phenyl]methanol has been explored for its potential use as a chiral auxiliary in asymmetric synthesis reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 103573-92-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,5,7 and 3 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 103573-92:
(8*1)+(7*0)+(6*3)+(5*5)+(4*7)+(3*3)+(2*9)+(1*2)=108
108 % 10 = 8
So 103573-92-8 is a valid CAS Registry Number.
InChI:InChI=1/C11H12N2O/c14-8-11-3-1-10(2-4-11)7-13-6-5-12-9-13/h1-6,9,14H,7-8H2
103573-92-8Relevant articles and documents
DEGRADABLE IMIDAZOLIUM OLIGOMER AND POLYMER FOR ANTIMICROBIAL APPLICATIONS
-
Page/Page column 34, (2019/01/16)
The present invention relates to an imidazolium oligomer of formula (I) and an imidazolium oligomer or a polymer of formula (II) where the various groups are as defined in the specification. The present invention also relates to the methods for their preparation, antimicrobial composition, antimicrobial gel containing these oligomers and/or polymers of Formula (I) and (II), and uses of these oligomers and/or polymers in the treatment of a microbial infection or disease.
Pyridyl ester containing 1,4-dihydropyridine derivatives and salts thereof and pharmaceutical composition containing the same
-
, (2008/06/13)
This invention relates to a novel 1,4-dihydropyridine derivative of the formula STR1 wherein R2 is pyridyl, or a salt thereof. These compounds have a vasodilating activity and a platelet aggregation inhibiting activity. Also disclosed are pharmaceutical compositions containing the same.
